Results 231 to 240 of about 227,347 (400)

Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts

open access: bronze, 1985
Bruce W. Lytle   +5 more
openalex   +1 more source

Recombinant Activated Factor VIIa Combined With Tranexamic Acid Control Haemostasis in Patients With Severe Factor XI Deficiency Undergoing Urological Procedures

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Patients with severe Factor XI deficiency face unique challenges during urological procedures due to an elevated risk of bleeding, balanced against the use of tranexamic acid (TXA), which may form blood clots. Given the limitations associated with plasma‐based treatment, there have been reports of successful and safe off‐label use
Neta Sternbach   +7 more
wiley   +1 more source

Online tool for cross‐sectional and longitudinal comparison of socio‐economic status indices based on postcodes in Australia

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Socio‐economic status (SES) is strongly associated with health outcomes, yet it remains relatively difficult to measure, particularly for longitudinal comparisons. Aim We have developed an interactive online tool (available at bit.ly/SEIFA-POA) that facilitates SES assessment based on postcodes (POA).
Andrzej S. Januszewski   +5 more
wiley   +1 more source

Biochemical and ultrastructural integrity of the saphenous vein conduit during coronary artery bypass grafting

open access: bronze, 1984
Arthur J. Roberts   +7 more
openalex   +1 more source

Coronary artery bypass grafting.

open access: yesAnnals of cardiothoracic surgery, 2013
Rebecca Harris   +2 more
openaire   +3 more sources

Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial

open access: yesCirculation, 2014
M. Morice   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy